Lachen (Switzerland)

Type: City
Name: Lachen (Switzerland)
Country: Switzerland
Latitude: 47.189999
Longitude: 8.84
population: 6,879
First reported Sep 26 2014 - Updated Sep 26 2014 - 1 reports

Stehlin parent restructures European ink sites

Hubergroup is rationalising its European set-up by merging its German operations and closing its factory in Lachen, Switzerland.Ward: we need a global approachMichael Huber München and Hostmann-Steinberg, the firm’s largest European operations will be ... [Published Print Week - Sep 26 2014]
First reported Aug 06 2014 - Updated Aug 06 2014 - 1 reports

European Commission publishes approval of Octapharma’s human cell line recombinant FVIII (Nuwiq®) across all age groups in haemophilia A

LACHEN, Switzerland--(BUSINESS WIRE)--European Commission publishes approval of Octapharma’s human cell line recombinant FVIII (Nuwiq®) across all age groups in haemophilia A for the treatment and prophylaxis of bleeding. ... [Published Business Wire Health News - Aug 06 2014]
First reported May 27 2014 - Updated May 28 2014 - 1 reports

Octapharma sponsors symposium “Spotlight on the human factor: building a foundation for the future of haemophilia A management" at 2014 WFH World Congress in Melbourne, Australia

LACHEN, Switzerland--(BUSINESS WIRE)--Octapharma sponsors symposium “Spotlight on the human factor: building a foundation for the future of haemophilia A management" at 2014 WFH World Congress in Melbourne, Australia ... [Published Business Wire Health News - May 27 2014]
First reported May 26 2014 - Updated May 27 2014 - 1 reports

European Medicines Agency (EMA) adopts positive opinion on Octapharma’s human cell line recombinant human FVIII (Nuwiq®) in children and adults with haemophilia A

LACHEN, Switzerland--(BUSINESS WIRE)--European Medicines Agency (EMA) adopts positive opinion on Octapharma’s human cell line recombinant human FVIII (Nuwiq®) in children and adults with haemophilia A ... [Published Business Wire Health News - May 26 2014]

More Content

All (4) | News (1) | Reports (0) | Blogs (3) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Stehlin parent restructures European ink sites [Published Print Week - Sep 26 2014]
European Commission publishes approval of Octap... [Published Business Wire Health News - Aug 06 2014]
Octapharma sponsors symposium “Spotlight on the... [Published Business Wire Health News - May 27 2014]
European Medicines Agency (EMA) adopts positive... [Published Business Wire Health News - May 26 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
European Commission publishes approval of Octap... [Published Business Wire Health News - Aug 06 2014]
LACHEN, Switzerland--(BUSINESS WIRE)--European Commission publishes approval of Octapharma’s human cell line recombinant FVIII (Nuwiq®) across all age groups in haemophilia A for the treatment and prophylaxis of bleeding. ...
Octapharma sponsors symposium “Spotlight on the... [Published Business Wire Health News - May 27 2014]
LACHEN, Switzerland--(BUSINESS WIRE)--Octapharma sponsors symposium “Spotlight on the human factor: building a foundation for the future of haemophilia A management" at 2014 WFH World Congress in Melbourne, Australia ...
European Medicines Agency (EMA) adopts positive... [Published Business Wire Health News - May 26 2014]
LACHEN, Switzerland--(BUSINESS WIRE)--European Medicines Agency (EMA) adopts positive opinion on Octapharma’s human cell line recombinant human FVIII (Nuwiq®) in children and adults with haemophilia A ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.